Immunologic aspects of melanoma.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000032:analysis*; D000918:Antibody Specificity; D000951:Antigens, Neoplasm / Q000032:analysis* / Q000145:classification; D000956:Antigens, Viral; D002051:Burkitt Lymphoma / Q000276:immunology; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic; D006382:Hemadsorption; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D008544:Melanocytes / Q000502:physiology; D008545:Melanoma / Q000209:etiology / Q000276:immunology* / Q000556:secondary; D058950:Melanoma-Specific Antigens; D009303:Nasopharyngeal Neoplasms / Q000276:immunology; D009363:Neoplasm Proteins / Q000032:analysis*; D009365:Neoplasm Regression, Spontaneous; D014466:Ultraviolet Rays
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins